Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05850234
Title A Study of GC012F, a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Gracell Biopharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Research Site RECRUITING Birmingham Alabama 35233 United States Details
Research Site RECRUITING Phoenix Arizona 85054 United States Details
Research Site NOT_YET_RECRUITING La Jolla California 92037 United States Details
Research Site RECRUITING Denver Colorado 80218 United States Details
Research Site NOT_YET_RECRUITING Jacksonville Florida 32224 United States Details
Research Site RECRUITING Rochester Minnesota 55905 United States Details
Research Site NOT_YET_RECRUITING New York New York 10065 United States Details
Research Site RECRUITING Stony Brook New York 11794 United States Details
Research Site NOT_YET_RECRUITING Nashville Tennessee 37203 United States Details
Research Site RECRUITING Nashville Tennessee 37203 United States Details
Research Site RECRUITING Austin Texas 78704 United States Details
Research Site NOT_YET_RECRUITING Dallas Texas 75390 United States Details
Research Site NOT_YET_RECRUITING Houston Texas 77030 United States Details
Research Site RECRUITING Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field